Literature DB >> 2186849

The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis.

R E Ariano, G G Zhanel, G K Harding.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2186849      PMCID： PMC1452004     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Cholestyramine treatment of pseudomembranous colitis.

Authors:  F Sinatra; W L Buntain; C H Mitchell; P Sunshine
Journal:  J Pediatr       Date:  1976-02       Impact factor: 4.406

2.  Multiple relapses of Clostridium difficile-associated diarrhea responding to an extended course of cholestyramine.

Authors:  P Pruksananonda; K R Powell
Journal:  Pediatr Infect Dis J       Date:  1989-03       Impact factor: 2.129

3.  Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; F J Tedesco; S Shull; B Lowe; T Chang
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

4.  Treatment of recurrent antibiotic-associated pseudomembranous colitis.

Authors:  F J Tedesco
Journal:  Am J Gastroenterol       Date:  1982-04       Impact factor: 10.864

5.  Anion-exchange resins in antibiotic-associated colitis.

Authors:  T W Chang; A B Onderdonk; J G Bartlett
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

6.  Antibiotic-associated pseudomembranous colitis: pathogenesis and management.

Authors:  M R Keighley
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

7.  Pseudomembranous colitis. Association with antibiotics and therapy with cholestyramine.

Authors:  E J Burbige; F D Milligan
Journal:  JAMA       Date:  1975-03-17       Impact factor: 56.272

8.  Treatment of antibiotic-associated pseudomembranous colitis with cholestyramine resin.

Authors:  E W Kreutzer; F D Milligan
Journal:  Johns Hopkins Med J       Date:  1978-09

9.  Recurrent Clostridium difficile-associated colitis responding to cholestyramine.

Authors:  D Kunimoto; A B Thomson
Journal:  Digestion       Date:  1986       Impact factor: 3.216

10.  Therapy of antibiotic-associated pseudomembranous colitis.

Authors:  F J Tedesco; J Napier; W Gamble; T W Chang; J G Bartlett
Journal:  J Clin Gastroenterol       Date:  1979-03       Impact factor: 3.062
  10 in total
  6 in total

Review 1.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Trends in Clostridium difficile Disease: Epidemiology and Intervention.

Authors:  David J Riddle; Erik R Dubberke
Journal:  Infect Med       Date:  2009

Review 3.  Clostridium difficile infection in the intensive care unit.

Authors:  David J Riddle; Erik R Dubberke
Journal:  Infect Dis Clin North Am       Date:  2009-09       Impact factor: 5.982

Review 4.  The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.

Authors:  M Andréjak; J L Schmit; A Tondriaux
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

Review 5.  Clostridium difficile infection: a common clinical problem for the general internist.

Authors:  G M Caputo; M R Weitekamp; A E Bacon; C Whitener
Journal:  J Gen Intern Med       Date:  1994-09       Impact factor: 5.128

6.  Metabolism of bile salts in mice influences spore germination in Clostridium difficile.

Authors:  Jennifer L Giel; Joseph A Sorg; Abraham L Sonenshein; Jun Zhu
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.